| Literature DB >> 36248372 |
Shaojie Yang1, Shuodong Wu1, Wanlin Dai2, Liwei Pang3, Yaofeng Xie4, Tengqi Ren5, Xiaolin Zhang1, Shiyuan Bi1, Yuting Zheng1, Jingnan Wang1, Yang Sun1, Zhuyuan Zheng1, Jing Kong1.
Abstract
Backgrounds/Aims: A history of upper abdominal surgery has been identified as a relative contraindication for laparoscopy. This study aimed to compare the clinical efficacy and safety of laparoscopic cholecystectomy (LC) and laparoscopic common bile duct exploration (LCBDE) in patients with and without previous upper abdominal surgery.Entities:
Keywords: abdominal adhesion; conversion to open surgery; laparoscopic cholecystectomy; laparoscopic common bile duct exploration; previous upper abdominal surgery
Year: 2022 PMID: 36248372 PMCID: PMC9562259 DOI: 10.3389/fsurg.2022.991684
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Areas of previous upper abdominal surgery.
| Group | Specific area of last surgery | Number |
|---|---|---|
| LC | 83 | |
| Right upper abdominal surgery (group A) | Gallbladder (13) | 17 |
| Other upper abdominal surgery (group B) | Colon (7) Kidney (16) Stomach (14) Small intestine (11) | 66 |
| LCBDE | 48 | |
| Right upper abdominal surgery (group C) | Gallbladder (16) CBD (13) Liver (1) | 30 |
| Other upper abdominal surgery (group D) | Colon (4) Kidney (2) Stomach (7) Small intestine (3) | 18 |
13 patients underwent minimally invasive cholecystolithotomy using laparoscopy combined with choledochoscopy.
Patient characteristics and preoperative observation index.
| LC | LCBDE | |||||
|---|---|---|---|---|---|---|
| Control | Group A | Group B | Control | Group C | Group D | |
| Gender (M:F) | 16:19 | 8:9 | 28:38 | 13:16 | 12:18 | 8:10 |
| Age (years) | 53.06 ± 13.19 (27–77) | 55.29 ± 13.79 (20–77) | 58.18 ± 13.64 (24–82) | 56.38 ± 15.85 (35–73) | 61.43 ± 7.14 (45–80) | 61.89 ± 9.04 (50–86) |
| blood biochemical examinations | ||||||
| WBC (*109/L) | 5.78 ± 1.82 | 5.63 ± 1.35 | 6.19 ± 2.11 | 6.27 ± 2.17 | 6.28 ± 2.52 | 5.37 ± 1.58 |
| ALT (U/L) | 50.06 ± 85.19 | 49.63 ± 58.84 | 25.48 ± 17.74 | 127.43 ± 179.71 | 100.23 ± 104.53 | 77.94 ± 99.52 |
| AST (U/L) | 25.00 ± 25.14 | 30.06 ± 21.36 | 25.39 ± 25.57 | 68.39 ± 92.95 | 67.57 ± 82.84 | 43.56 ± 35.33 |
| BILD (µmol/L) | 5.16 ± 4.38 | 5.43 ± 4.22 | 6.03 ± 4.70 | 18.35 ± 23.51 | 18.79 ± 26.68 | 11.49 ± 11.94 |
| BILT (µmol/L) | 13.13 ± 7.52 | 15.96 ± 9.56 | 15.86 ± 9.16 | 29.14 ± 28.49 | 30.01 ± 31.68 | 21.53 ± 16.40 |
All p-value >0.05; WBC: white blood cell, ALT: alanine aminotransferase, AST: aspartate aminotransferase, BILD: direct bilirubin, BILT: total bilirubin.
Comparison of operative results.
| LC | LCBDE | ||||||
|---|---|---|---|---|---|---|---|
| Control ( | Group A ( | Group B ( | Control ( | Group C ( | Group D ( | ||
| Adhesion | No adhesions | 13 (37.2) | 5 (29.4) | 17 (25.7) | 7 (24.1) | 3 (10.0) | 1 (5.6) |
| Filmy Ddhesions | 16 (45.7) | 5 (29.4) | 19 (28.8) | 17 (58.6) | 5 (16.7) | 7 (38.9) | |
| dense adhesions | 6 (17.1) | 7 (41.2) | 30 (45.5) | 5 (17.3) | 22 (73.3) | 10 (55.5) | |
| Estimated blood loss (ml) | 15.14 ± 22.80 | 13.13 ± 6.80 | 18.77 ± 16.65 | 18.97 ± 13.12 | 41.33 ± 50.84 | 66.11 ± 87.46 | |
| Hemostasis | Electrocautery | 7 (20.0) | 5 (29.4) | 34 (51.5) | 29 (100) | 30 (100) | 18 (100) |
| Hemostatic gauze | 9 (25.7) | 5 (29.4) | 19 (28.8) | 14 (48.3) | 25 (83.3) | 12 (66.7) | |
| Operation time (min) | 63.74 ± 24.00 | 75.06 ± 33.90 | 70.00 ± 30.00 | 138.38 ± 57.38 | 173.87 ± 60.91 | 128.61 ± 48.95 | |
p-value <0.05.
Comparison of postoperative laboratory tests.
| LC | LCBDE | |||||
|---|---|---|---|---|---|---|
| Control | Group A | Group B | Control | Group C | Group D | |
| WBC (*109/L) | 9.29 ± 2.32 | 9.58 ± 3.37 | 9.68 ± 4.02 | 12.69 ± 4.29 | 12.70 ± 4.03 | 11.32 ± 3.12 |
| ALT (U/L) | 62.83 ± 76.04 | 57.82 ± 60.71 | 45.36 ± 44.37 | 49.12 ± 32.84 | 66.27 ± 28.84 | 49.06 ± 32.78 |
| AST (U/L) | 46.09 ± 41.63 | 38.94 ± 28.30 | 42.95 ± 39.78 | 46.03 ± 23.35 | 49.13 ± 26.91 | 44.28 ± 17.70 |
| BILD (µmol/L) | 8.46 ± 7.93 | 6.46 ± 2.86 | 8.71 ± 11.07 | 11.14 ± 7.03 | 15.34 ± 14.06 | 12.52 ± 8.53 |
| BILT (µmol/L) | 20.77 ± 11.71 | 18.66 ± 7.68 | 21.37 ± 16.39 | 21.73 ± 8.96 | 27.26 ± 17.38 | 24.40 ± 13.82 |
All p-value >0.05.
Postoperative observation indexes and complications.
| LC | LCBDE | |||||
|---|---|---|---|---|---|---|
| Control | Group A | Group B | Control | Group C | Group D | |
| Drainage volume (ml) | 26.57 ± 69.77 | 50.06 ± 83.66 | 60.29 ± 123.78 | 150.83 ± 127.04 | 296.83 ± 282.97 | 176.11 ± 174.76 |
| Postoperative hospital stay (days) | 4.09 ± 1.04 | 4.00 ± 1.46 | 4.48 ± 1.46 | 6.17 ± 1.63 | 7.97 ± 3.68 | 6.61 ± 3.07 |
| Hospitalization costs (RMB) | 23,636.85 ± 7,063.29 | 26,932.54 ± 11,898.31 | 26,160.39 ± 6,972.70 | 41,108.36 ± 11,130.72 | 48,178.34 ± 22,038.57 | 45,398.03 ± 11,546.99 |
| Postoperative complication | 0 | 0 | 1 (1.5%) | 0 | 2 (6.7%) | 0 |
p-value <0.05.
The complication grades according to the Clavien–Dindo classification system.
| Grade according to the Clavien–Dindo classification system (%) | LC | LCBDE | ||||
|---|---|---|---|---|---|---|
| Control ( | Group A ( | Group B ( | Control ( | Group C ( | Group D ( | |
| I | 34 (97.14) | 16 (94.12) | 62 (93.94) | 25 (86.21) | 25 (83.33) | 16 (88.89) |
| II | 1 (2.86) | 1 (5.88) | 3 (4.54) | 4 (13.79) | 4 (13.33) | 2 (11.11) |
| III | 0 | 0 | 1 (1.52) | 0 | 1 (3.34) | 0 |
| IV | 0 | 0 | 0 | 0 | 0 | 0 |
All p-value >0.05.